NCT02179268View on ClinicalTrials.gov

Antidepressants and Bone Mineral Density

PHASE3CompletedINTERVENTIONAL
Enrollment

203

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Bone Mineral Density Quantitative Trait Locus 7
Interventions
DRUG

sertraline

50mg, 50-150mg/d,qd for one year

DRUG

citalopram

20mg, 20-40mg/d,qd,for one year

DRUG

venlafaxine

venlafaxine,25mg, 75-100mg/d, bid, for one year

DRUG

reboxetine

reboxetine,4mg, 4-8mg/d,qd for one year

BEHAVIORAL

control

50min, every week for three months, every month, for nine months

All Listed Sponsors
lead

Guiyang Medical University

OTHER

NCT02179268 - Antidepressants and Bone Mineral Density | Biotech Hunter | Biotech Hunter